Ramachandran Murali serves as Executive at Kairos Pharma, LTD., where they oversee executive responsibilities. Since joining the company, Ramachandran Murali has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 8, 2025 involved receiving (via award) 152,672 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 8, 2025 | KAPA | $0 | Award | 152,672 | $N/A | Discretionary |
Ramachandran Murali currently holds 299,529 shares of Kairos Pharma, LTD. (KAPA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ramachandran Murali has been a net neutral trader of KAPA stock. They have purchased $0 and sold $0 worth of shares.
Ramachandran Murali's most recent insider trade was on Oct 8, 2025, when they sold 152,672 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted